Orforglipron / SLU-PP-332 Capsules

Orforglipron / SLU-PP-332 capsules are a research-grade formulation designed for the study of metabolic and cellular signaling pathways. Orforglipron is an orally active GLP-1 receptor agonist investigated for its role in glucose regulation and appetite signaling, while SLU-PP-332 is a synthetic ERR agonist studied for its potential effects on mitochondrial activity and energy metabolism.

This combination may support research into metabolic function, energy utilization, and exercise-mimetic pathways. Manufactured for precision and consistency, each capsule is intended strictly for laboratory and research use only.